Figure_6.tif (52.04 kB)
MDAPCV (%) present in tumors after intratumoral injection of MDAP3000 with or without MMP inhibitor (GM6001).
figure
posted on 2014-07-10, 03:14 authored by Takashi Temma, Hirofumi Hanaoka, Aki Yonezawa, Naoya Kondo, Kohei Sano, Takeharu Sakamoto, Motoharu Seiki, Masahiro Ono, Hideo SajiMDAPCV (%) present in tumors after intratumoral injection of MDAP3000 with or without MMP inhibitor (GM6001).
History
Usage metrics
Categories
Keywords
BiochemistryenzymologyEnzyme chemistryEnzyme regulationenzymesbiophysicsBionanotechnologybiotechnologybiomaterialsSmall moleculesneuroscienceneuroimagingSingle photon emission computed tomographyClinical medicineoncologyBasic cancer researchmetastasisCancer treatmentRadiation therapyCancer detection and diagnosisOncology agentspharmacologyDrug research and developmentdrug discoverypharmacokineticsDrug distributionRadiopharmaceuticalsRadiology and imagingchemistryNuclear chemistryRadiochemistrytumorsintratumoralinjectionmmpinhibitor
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC